Search
Filter by content type
Filter by content year
Filter by category
BioNTech and Fosun Pharma Announce Start of Clinical Trial of mRNA-based COVID-19 Vaccine Candidate in China
August 5, 2020 - … BioNTech and Fosun Pharma Announce Start of Clinical Trial of mRNA-based … COVID-19 Vaccine Candidate in China … BioNTech and Fosun Pharma Announce Start of Clinical Trial of mRNA-based … COVID-19 Vaccine Candidate in China BioNTech and Fosun Pharma Announce Start of Clinical Trial of mRNA-based …
BioNTech to Present New Clinical Data from First-in-Class CAR-T Program BNT211 in Late-breaking Session at 36th SITC Annual Meeting
November 1, 2021 - … a member of the Roche Group, Regeneron, Genevant, Fosun Pharma and Pfizer. For more information, please visit … a member of the Roche Group, Regeneron, Genevant, Fosun Pharma and Pfizer. For more information, please visit … a member of the Roche Group, Regeneron, Genevant, Fosun Pharma and Pfizer. For more information, please visit …
BioNTech und Fosun Pharma beginnen klinische Studie mit mRNA-basiertem COVID-19-Impfstoffkandidaten in China
August 5, 2020 - … BioNTech und Fosun Pharma beginnen klinische Studie mit mRNA-basiertem … COVID-19-Impfstoffkandidaten in China … BioNTech und Fosun Pharma beginnen klinische Studie mit mRNA-basiertem … COVID-19-Impfstoffkandidaten in China BioNTech und Fosun Pharma beginnen klinische Studie mit mRNA-basiertem …
BioNTech and Pfizer Initiate Rolling Submission to European Medicines Agency for SARS-CoV-2 Vaccine Candidate BNT162b2
October 6, 2020 - … a member of the Roche Group, Regeneron, Genevant, Fosun Pharma, and Pfizer. For more information, please visit … a member of the Roche Group, Regeneron, Genevant, Fosun Pharma, and Pfizer. For more information, please visit … a member of the Roche Group, Regeneron, Genevant, Fosun Pharma, and Pfizer. For more information, please visit …
BioNTech präsentiert neue klinische Daten aus seinem ersten CAR-T-Programm BNT211 in Late-Breaking-Kurzvortrag auf der 36. SITC-Jahrestagung
November 1, 2021 - … (ein Unternehmen der Roche Gruppe), Regeneron, Genevant, Fosun Pharma und Pfizer. Weitere Information finden Sie … (ein Unternehmen der Roche Gruppe), Regeneron, Genevant, Fosun Pharma und Pfizer. Weitere Information finden Sie … (ein Unternehmen der Roche Gruppe), Regeneron, Genevant, Fosun Pharma und Pfizer. Weitere Information finden Sie …
BioNTech and DualityBio Receive FDA Fast Track Designation for Next-Generation Antibody-Drug Conjugate Candidate BNT325/DB-1305
January 31, 2024 - … pharmaceutical collaborators, including Duality Biologics, Fosun Pharma, Genentech, a member of the Roche Group, … pharmaceutical collaborators, including Duality Biologics, Fosun Pharma, Genentech, a member of the Roche Group, … pharmaceutical collaborators, including Duality Biologics, Fosun Pharma, Genentech, a member of the Roche Group, …
Pfizer and BioNTech Announce Vaccine Candidate Against COVID-19 Achieved Success in First Interim Analysis from Phase 3 Study
November 9, 2020 - … a member of the Roche Group, Regeneron, Genevant, Fosun Pharma, and Pfizer. For more information, please visit … a member of the Roche Group, Regeneron, Genevant, Fosun Pharma, and Pfizer. For more information, please visit … a member of the Roche Group, Regeneron, Genevant, Fosun Pharma, and Pfizer. For more information, please visit …
An In Vitro Study Shows Pfizer-BioNTech COVID-19 Vaccine Elicits Antibodies that Neutralize SARS-CoV-2 with a Mutation Associated with Rapid Transmission
January 8, 2021 - … a member of the Roche Group, Regeneron, Genevant, Fosun Pharma, and Pfizer. For more information, please visit … a member of the Roche Group, Regeneron, Genevant, Fosun Pharma, and Pfizer. For more information, please visit … a member of the Roche Group, Regeneron, Genevant, Fosun Pharma, and Pfizer. For more information, please visit …
Pfizer and BioNTech Announce Publication of Results from Landmark Phase 3 Trial of BNT162b2 COVID-19 Vaccine Candidate in The New England Journal of Medicine
December 10, 2020 - … a member of the Roche Group, Regeneron, Genevant, Fosun Pharma, and Pfizer. For more information, please visit … a member of the Roche Group, Regeneron, Genevant, Fosun Pharma, and Pfizer. For more information, please visit … a member of the Roche Group, Regeneron, Genevant, Fosun Pharma, and Pfizer. For more information, please visit …
Pfizer and BioNTech Choose Lead mRNA Vaccine Candidate Against COVID-19 and Commence Pivotal Phase 2/3 Global Study
July 27, 2020 - … Health, Genentech, a member of the Roche Group, Genevant, Fosun Pharma, and Pfizer. For more information, please visit … Health, Genentech, a member of the Roche Group, Genevant, Fosun Pharma, and Pfizer. For more information, please visit … Health, Genentech, a member of the Roche Group, Genevant, Fosun Pharma, and Pfizer. For more information, please visit …